Pure Global AI
NCT06229106Recruiting

Symfony vs Vivity in Dim Light

Evaluation of the Symfony With Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions
Carolina Eyecare Physicians, LLCPhase 4ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Cataract
Drug/Device/Intervention
Symfony IOL
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Carolina Eyecare Physicians, LLC
Location
Sarasota,Mount Pleasant, United States of America
Timeline & enrollment
Phase
Phase 4
Start date
Dec 01, 2023
End date
Dec 31, 2024
Enrollment
64 participants
Primary outcome

Binocular distance corrected intermediate visual acuity at 66 cm under mesopic conditions.

Summary

The purpose of this study is to evaluate the visual outcomes of the Symfony lens and the
 Vivity lens under mesopic lighting conditions in adult patients undergoing routine cataract
 surgery. Participants will be asked to read a visual acuity chart at different distances in
 dim light.

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06229106
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06229106 through Pure Global AI's free database. This Phase 4 trial is sponsored by Carolina Eyecare Physicians, LLC and is currently Recruiting. The study focuses on Cataract. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.